Abstract
Stem cells possess the ability to self-renew by symmetric divisions and, under certain circumstances, differentiate to a committed lineage by asymmetric cell divisions. Depending on the origin, stem cells are classified as either embryonic or adult. Embryonic stem cells are obtained from the inner cell mass of the blastocyst, a structure that appears during embryonic development at day 6 in humans and day 3.5 in mice. Adult stem cells are present within tissues of adult organisms and are responsible for cell turnover or repopulation of tissues under normal or exceptional circumstances. Taken together, stem cells might represent a potential source of tissues for cell therapy protocols, and diabetes is a candidate disease that may benefit from cell replacement protocols. The pathology of type 1 diabetes is caused by the autoimmune destruction or malfunction of pancreatic β cells, and consequently, a lack of insulin. The absence of insulin is life-threatening, thus requiring diabetic patients to take daily hormone injections from exogenous sources; however, insulin injections do not adequately mimic β cell function. This results in the development of diabetic complications such as neuropathy, nephropathy, retinopathy and diverse cardiovascular disorders. This chapter intends to summarize the possibilities opened by embryonic and adult stem cells in regenerative medicine for the cure of diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baeyens L, De Breuck S, Lardon J, Mfopou JK, Rooman I, Bouwens L (2005) In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48:49–57
Barshes NR, Lee T, Goodpasture S, Brunicardi FC, Alejandro R, Ricordi C, Soltes G, Barth M, Hamilton D, Goss JA (2004) Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. Transplant Proc 36:1127–1129
Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in β-cell function. Nature 414:788–791
Benoist C, Mathis D (1997) Cell death mediators in autoimmune diabetes. No shortage of suspects. Cell 89:1–3
Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, Wobus A (2003) Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 100:998–1003
Blyszczuk P, Asbrand C, Rozzo A, Kania G, St-Onge L, Rupnik M, Wobus AM (2004) Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. Int J Dev Biol 48:1095–1104
Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song K-H, Sharma A, O’Neil JJ (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 97:7999–8004
Brandhorst H, Brandhorst D, Hess F, Ambrosius D, Brendel M, Kawakami Y, Bretzel RG (2003) Successful human islet isolation utilizing recombinant collagenase. Diabetes 52:1143–1146
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559–569
Chakrabarti SK, Mirmira RG (2003) Transcription factors direct the development and function of pancreatic β cells. Trends Endocrinol Metab 14:78–84
Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, Mochizuki H, Migita M, Shimada T, Kawamori R, Watada H (2003) Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 46:1366–1374
DeFronzo RA, Ferrannini E, Keen H, Zimmet P (2004) International textbook of diabetes mellitus, 3rd edn. John Wiley, Chichester, UK
Dor Y, Brown J, MartÍnez OI, Melton DA (2004) Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46
Efrat S (1998) Prospects for gene therapy of insulin-dependent diabetes mellitus. Diabetologia 41:1401–1409
Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A (2000) Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 6:568–572
Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: stem cells and their niche. Cell 116:769–778
Gage FH, Ray J, Fisher LJ (1995) Isolation, characterization, and use of stem cells from CNS. Annu Rev Neurosci 18:159–192
Georges P, Muirhead RP, Williams L, Holman S, Tabiin MT, Dean SK, Tuch BE (2002) Comparison of size, viability, and function of fetal pig islet-like cell clusters after digestion using collagenase or liberase. Cell Transplant 11:539–545
Gray DW, Sudhakaran N, Titus TT, McShane P, Johnson P (2004) Development of a novel digestion chamber for human and porcine islet isolation. Transplant Proc 36:1135–1138
Hernández-Sánchez C, Mansilla A, de la Rosa EJ, Pollerberg GE, MartÍnez-Salas E, de Pablo F (2003) Upstream AUGs in embryonic proinsulin mRNA control its low translation level. EMBO J 22:5582–5592
Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotech 21:763–770
Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK (2002) Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 99:16105–16110
Ianus A, Holz GG, Theise ND, Hussain MA (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111:843–850
Jamal A-M, Lipstt M, Hazrati A, Paraskevas S, Agapitos D, Maysinger D, Rosenberg L (2003) Signals for death and differentiation: a two-step mechanism for in vitro transformation of adult islets of Langerhans to duct epithelial structures. Cell Death Diff 10:987–996
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-González XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Lew WC, Largaespada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49
Kania G, Blyszczuk P, Wobus AM (2004) The generation of insulin-producing cells from embryonic stem cells-a discussion of controversial findings. J Dev Biol 48:1061–1064
Kim SK, Hebrok M (2001) Intercellular signals regulating pancreas development and function. Genes Dev 15:111–127
Klug MG, Soonpa MH, Koh GY, Field LJ (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98:216–224
Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda, H, Maeda M, Chan L (2003) NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 9:596–603
Ku HT, Zhang N, Kubo A, O’Connor R, Mao M, Keller G, Bromberg JS (2004) Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 22:1205–1217
Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, Fehling HJ, Keller G (2004) Development of definitive endoderm from embryonic stem cells in culture. Development 131:1651–1662
Lammert E, Cleaver O, Melton D (2001) Induction of pancreatic differentiation by signals from blood vessels. Science 294:564–567
Lechner A, Yang Y-G, Blacken RA, Wang L, Nolan AL, Habener JF (2004) No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo. Diabetes 53:616–623
León-Quinto T, Jones J, Skoudy A, Burcin M, Soria B (2004) In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47:1442–1451
Li M, Pevny L, Lovell-Badge R, Smith A (1998) Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 8:971–974
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389–1394
Maechler P, Wollheim CB (2001) Mitochondrial function in normal and diabetic β-cells. Nature 414:807–812
Mathis D, Vence L, Benoist C (2001) β-Cell death during progression to diabetes. Nature 414:792–798
Melloul D, Marshak S, Cerasi E (2002) Regulation of insulin gene transcription. Diabetologia 45:309–326
Milne HM, Burns CJ, Kitsou-Mylona IK, Luther MJ, Minger SL, Persaud SJ, Jones PM (2005) Generation of insulin-expressing cells from mouse embryonic stem cells. Biochem Biophys Res Commun 328:399–403
Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631–642
Miyazaki S, Yamato E, Miyazaki J (2004) Regulated expression of Pdx1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 53:1030–1037
Moritoh Y, Yamato E, Yasui Y, Miyazaki S, Miyazaki J (2003) Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 52:1163–1168
Müller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, Müller OJ, Schlenke P, Frese S, Wobus AM, Hescheler J, Katus HA, Franz WM (2000) Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14:2540–2548
Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372–376
Oluwole SF, Oluwole OO, Adeyeri AO, DePaz HA (2004) New strategies in immune tolerance induction. Cell Biochem Biophys Suppl 40:27–48
Pesce M, Gross MK, Scholer HR (1998) In line with our ancestors: Oct4 and the mammalian germ. Bioessays 20:722–732
Piper K, Ball SG, Turnpenny LW, Brickwod S, Wilson DI, Hanley NA (2002) Beta-cell differentiation during human development does not rely on nestin-positive precursors: implications for stem cell-derived replacement therapy. Diabetologia 45:1045–1047
Podolsky DK (1993) Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol 264:G179–G186
Poitout V, Robertson RP (1996) An integrated view of β-cell dysfunction in type 2 diabetes. Annu Rev Med 47:69–83
Polak M, Bouchareb-Banaei L, Scharfmann R, Czernichow P (2000) Early pattern of differentiation in the human pancreas. Diabetes 49:225–232
Polonsky KS, Sturis J, Bell GI (1996) Non-insulin dependent diabetes mellitus. A genetically programmed failure of the β-cell to compensate for insulin resistance. N Engl J Med 334:777–783
Potten CS, Loeffler M (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110:1001–1020
Prentki M, Roduit R, Lameloise N, Corkey BE Assimacopoulos-Jeannet F (2000) Glucotoxicity, lipotoxicity and pancreatic β-cell failure: a role for malonyl-CoA, PPARα and altered lipid partitioning? Can J Diabetes Care 25:36–46
Rajagopal J, Anderson WJ, Kume S, MartÍnez OI, Melton DA (2003) Insulin staining of ES cell progeny from insulin uptake. Science 299:363
Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG (2000) Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med 6:278–282
Roche E (2003) Type 2 diabetes: gluco-lipo-toxicity and pancreatic β-cell dysfunction. Ars Pharmaceutica 44:313–332
Roche E, Sepulcre MP, Enseñat-Waser R, Maestre I, Reig JA, Soria B (2003) Bio-engineering insulin-secreting cells from embryonic stem cells: a review of progress. Med Biol Eng Comp 41:384–391
Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schorman W, Hengstler JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch RM, Heeckt P, Kremer B, Fändrich F (2005) Differentiation of in-vitro modified human peripheral monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 128:174–1786
Ryan EA, Lakey JRT, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AMJ (2002) Successful islet transplantation. Continued insulin reserve provides long-term glycemic control. Diabetes 51:2148–2157
Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517–529
Segev H, Fishman B, Ziskind A, Shulman M, Itskovitz-Eldor J (2004) Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22:265–274
Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a corticoid-free immunosuppressive regime. N Eng J Med 343:230–238
Smith AG (1991) Culture and differentiation of embryonic stem cells. J Tissue Culture Methods 13:89–94
Smith AG (2001) Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17:435–462
Soria B, Roche E, Berná G, León-Quinto T, Reig JA, Martín F (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157–162
Soria B, Skoudy A, Martín F (2001) From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44:407–415
Tanaka TS, Kunath T, Kimber WL, Jaradat SA, Stagg CA, Usuda M, Yokota T, Niwa H, Rossant J, Ko MS (2002) Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. Genome Res 12:1921–1928
Thorgeirsson SS (1996) Hepatic stem cells in liver regeneration. FASEB J 10:1249–1256
Toyooka Y, Tsunekawa N, Takahashi Y, Matsui Y, Satoh M, Noce T (2000) Expression and intracellular localization of mouse Vasa-homologue protein during germ cell development. Mech Dev 93:139–149
Treutelaar MK, Skidmore JM, Dias-Leme CL, Hara M, Zhang L, Simeone D, Martin DM, Burant CF (2003) Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes 52:2503–2512
Vicario-Abejón C, Yusta-Boyo MJ, Fernández-Moreno C, de Pablo F (2003) Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. J Neurosci 23:895–906
Wagers AJ, Weissman IL (2004) Plasticity of adult stem cells. Cell 116:639–648
Wobus AM, Boheler KR (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:636–678
Yang L, Li S, Hatch H, Ahrens K, Cornelius JG, Petersen BE, Peck AB (2002) In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci U S A 99:8078–8083
Ying Q-L, Stavridis M, Griffiths D, Li M, Smith A (2003) Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 21:183–186
Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg 80:1745–1757
Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S (2003) Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci U S A 100:7253–7258
Zierath JR, Krook A, Wallberg-Henriksson H (2000) Insulin action and insulin resistance in human skeletal muscle. Diabetologia 43:821–835
Zimmet P, Alberti KGMM, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787
Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritzs W, Müller B, Vallejo M, Thomas MK, Habener JF (2001) Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes. Diabetes 50:521–533
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Roche, E., Enseñat-Waser, R., Reig, J., Jones, J., León-Quinto, T., Soria, B. (2006). Therapeutic Potential of Stem Cells in Diabetes. In: Wobus, A.M., Boheler, K.R. (eds) Stem Cells. Handbook of Experimental Pharmacology, vol 174. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31265-X_7
Download citation
DOI: https://doi.org/10.1007/3-540-31265-X_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-26133-9
Online ISBN: 978-3-540-31265-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)